Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
Milad Daneshi-MaskooniSeyed Ali KeshavarzMostafa QorbaniSiavash MansouriSeyed Moayed AlavianMahtab Badri-FarimanSeyed Ali Jazayeri-TehraniGity SotoudehPublished in: BMC complementary and alternative medicine (2019)
Iranian Registry of Clinical Trials, IRCT2015121317254N4 . Registered 27/12/2015.
Keyphrases
- clinical trial
- double blind
- placebo controlled
- phase ii
- phase iii
- open label
- end stage renal disease
- weight loss
- ejection fraction
- study protocol
- chronic kidney disease
- newly diagnosed
- adipose tissue
- type diabetes
- metabolic syndrome
- randomized controlled trial
- physical activity
- phase ii study
- patient reported outcomes
- rectal cancer
- patient reported
- fatty acid
- locally advanced